Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
GlaxoSmithKline (GSK)
NYSE:GSK
Holding GSK?
Track your performance easily
GSK Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$32.83 - $45.93
Previous Close$33.43
Volume6.81M
Average Volume (3M)5.81M
Market Cap
$67.81B
Enterprise Value$82.82B
Total Cash (Recent Filing)£5.18B
Total Debt (Recent Filing)£18.02B
Price to Earnings (P/E)21.5
Beta0.34
Next Earnings
Feb 05, 2025EPS Estimate
$0.5Last Dividend Ex-Date
Nov 15, 2024Dividend Yield4.57%
Share Statistics
EPS (TTM)1.55
Shares Outstanding2,072,559,667
10 Day Avg. Volume4,224,279
30 Day Avg. Volume5,812,445
Standard Deviation0.07
R-Squared0.25
Alpha-0.00703
Financial Highlights & Ratios
Price to Book (P/B)9.68
Price to Sales (P/S)1.74
Price to Cash Flow (P/CF)13.20
P/FCF Ratio20.60
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
$36.17Price Target Upside7.65% Upside
Rating ConsensusHold
Number of Analyst Covering5
GlaxoSmithKline News
Ownership Overview
―
Insiders
4.63% Mutual Funds
9.13% Other Institutional Investors
86.00% Public Companies and Individual Investors
Risk Analysis
Main Risk Category
Legal & RegulatoryLitigation, compliance, new legislation, and taxation risks
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
GSK FAQ
What was GlaxoSmithKline’s price range in the past 12 months?
GlaxoSmithKline lowest stock price was $32.83 and its highest was $45.92 in the past 12 months.
What is GlaxoSmithKline’s market cap?
Currently, no data Available
When is GlaxoSmithKline’s upcoming earnings report date?
GlaxoSmithKline’s upcoming earnings report date is Feb 05, 2025 which is in 46 days.
How were GlaxoSmithKline’s earnings last quarter?
GlaxoSmithKline released its earnings results on Oct 30, 2024. The company reported $1.293 earnings per share for the quarter, beating the consensus estimate of $1.152 by $0.141.
Is GlaxoSmithKline overvalued?
According to Wall Street analysts GlaxoSmithKline’s price is currently Undervalued.
Does GlaxoSmithKline pay dividends?
GlaxoSmithKline pays a Quarterly dividend of $0.381 which represents an annual dividend yield of 4.57%. See more information on GlaxoSmithKline dividends here
What is GlaxoSmithKline’s EPS estimate?
GlaxoSmithKline’s EPS estimate is $0.5.
How many shares outstanding does GlaxoSmithKline have?
GlaxoSmithKline has 2,072,559,600 shares outstanding.
What happened to GlaxoSmithKline’s price movement after its last earnings report?
GlaxoSmithKline reported an EPS of $1.293 in its last earnings report, beating expectations of $1.152. Following the earnings report the stock price went down -3.046%.
Which hedge fund is a major shareholder of GlaxoSmithKline?
Among the largest hedge funds holding GlaxoSmithKline’s share is Dodge & Cox. It holds GlaxoSmithKline’s shares valued at 3B.
---
GlaxoSmithKline Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Hold
Average Price Target:
$36.17 (7.65% Upside)
$36.17 (7.65% Upside)
Blogger Sentiment
Bullish
GSK Sentiment 92%
Sector Average 70%
Sector Average 70%
Hedge Fund Trend
Increased
By 2.4M Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Positive
Last 7 Days ▼ 0.2%
Last 30 Days ▲ 2.5%
Last 30 Days ▲ 2.5%
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-3.56%
12-Months-Change
Fundamentals
Return on Equity
18.18%
Trailing 12-Months
Asset Growth
4.82%
Trailing 12-Months
Company Description
GlaxoSmithKline
Founded in 1715 and headquartered in Brentford, U.K., GlaxoSmithKline Plc is a global healthcare company which develops and manufactures pharmaceutical medicines in therapeutic areas, vaccines and consumer healthcare products in wellness, oral health, nutrition, and skin health categories.
---
GSK Company Deck
---
GSK Earnings Call
Q3 2024
0:00 / 0:00
Earnings Call Sentiment|Neutral
The earnings call presented a mix of strong financial growth and pipeline progress, particularly in Specialty Medicines, offset by challenges in the vaccine segment and specific market difficulties. The resolution of Zantac litigation is a positive development, yet the financial impact from it and the expected pressures from the U.S. Inflation Reduction Act present challenges.Read More>---
GSK Stock 12 Month Forecast
Average Price Target
$36.17
▲(7.65% Upside)
Technical Analysis
Best Analysts Covering GSK
1 Year
1 Year Success Rate
7/13 ratings generated profit
1 Year Average Return
-1.66%
reiterated a sell rating 15 days ago
Copying Graham Parry's trades and holding each position for 1 Year would result in 53.85% of your transactions generating a profit, with an average return of -1.66% per trade.
---